Indian Spice SHRINKS Pancreatic Tumors in HALF

Has one of the deadliest cancers around finally met its Kryptonite?

There’s no such thing as “good” cancer – but being diagnosed with pancreatic cancer is especially brutal.

The five-year survival rate is just 13% — and that’s after scorching radiation and toxic chemotherapy have wrecked your health and quality of life.

But researchers are now discovering a powerful Indian spice that’s doing what traditional cancer treatments can’t.

It’s targeting cancer cells that chemo and radiation miss…

It even shrunk tough-to-treat pancreatic tumors in half…

And it just may be the breakthrough that cancer patients have been waiting for.

Chemotherapy and radiation have always had a dirty secret – and it’s one that allows cancer to return with a vengeance.

You see, even if they kill 99% of your tumor, there’s a 1% that matters A LOT.

Those are cancer stem cells. And they resist traditional treatments.

And they can keep tumors coming back again… and again… and again.

That’s what makes the compound piperlongumine so unique.

It’s extracted from long pepper, a spice used in Ayurvedic medicine for thousands of years. And it does what traditional cancer treatments often fail to do – target cancer stem cells.

And when researchers tested piperlongumine against pancreatic cancer – one of the deadliest cancers around – the results were remarkable.

In studies with mice carrying implanted human pancreatic tumors, piperlongumine was given daily for 30 days.

The tumors shrank to an impressive 50% of the control group’s size.

And then researchers noticed something even more important… The compound was attacking cancer stem cells—the “root cells” that drive tumor regrowth and metastasis.

See, cancer stem cells are different from regular cancer cells. They divide slowly, which is why chemo misses them. They resist radiation and they hide in protective niches throughout your body.

Think of them as the roots of a weed. You can cut down the visible plant with chemo, but if the roots survive, it grows back. Piperlongumine goes after the roots.

In oral cancer research, piperlongumine suppressed tumor sphere formation—the clusters of stem cells that seed new growth. It also reduced markers that keep these cells capable of regenerating entire tumors.

And piperlongumine doesn’t just target stem cells. It makes standard treatments work better.

When researchers combined it with radiation therapy, cancer cells became 47.5% more sensitive. When combined with 5-FU chemotherapy, sensitivity increased again.

The compound works through two main pathways. First, it generates reactive oxygen species that push cancer cells past their stress threshold while normal cells stay protected.

Second, it blocks NF-κB signaling—the pathway cancer uses to resist treatment and spread.

Mention piperlongumine to your oncologist and they’ll probably say they’re not familiar. And they’re not—because it wasn’t part of their training. The research exists in journals, not in medical school curricula.

But unfamiliar doesn’t mean ineffective.

Piperlongumine supplements are available as long pepper extract, though quality varies.  Look for standardized products with verified piperlongumine content.

Most of the research to date comes from laboratory and animal studies, and human clinical data remains limited. If you’re interested in exploring piperlongumine, it’s important to talk with your oncologist or an integrative health professional to determine what’s appropriate for your individual situation.

To treating the root of cancer,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

• Dhillon H, Mamidi S, McClean P, Reindl KM. Piperlongumine induces pancreatic cancer cell death by enhancing reactive oxygen species and DNA damage. Toxicology Reports. 2014;1:309-318. https://pmc.ncbi.nlm.nih.gov/articles/PMC4268771/
• Wang Y, Wang JW, Xiao X, et al. Piperlongumine suppresses growth and sensitizes pancreatic tumors to gemcitabine in a xenograft mouse model by modulating the NF-kappa B pathway. Cancer Prevention Research. 2016;9(3):234-244. https://pubmed.ncbi.nlm.nih.gov/26667450/
• Chen YJ, Chiang TH, Wu HF, et al. Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer. Oncology Letters. 2018;15(2):1789-1798. https://pubmed.ncbi.nlm.nih.gov/29399195/
• Parama D, Boruah M, Yachna K, et al. The promising potential of piperlongumine as an emerging therapeutics for cancer. Pharmacological Research. 2021;170:105536. https://pmc.ncbi.nlm.nih.gov/articles/PMC9400693/